Between June 11th and 13th our representation attended the 14th Annual Biomarkers & Immuno-Oncology World Congress in Boston, one of the top world conferences about biomarker discovery and translational science for cancer treatment.
During the Congress, we had the opportunity to listen and interact with world top specialists in the field. We discussed talks and posters and gathered cutting-edge knowledge paying special attention to biomarkers for patient stratification, clinical trials design and strategies for rational treatment combination. During the poster sessions, we presented the latest results of our novel approach to translational science for immuno-oncology, catching the attention of various attendees.
Among the inspiring topics, we were able to hear about the latest results in biomarker detection and synergistic combination, liquid biopsy, and neoepitope research.
